|
- 2016
影响慢性乙型肝炎病毒感染患者肾功能的危险因素
|
Abstract:
[1] | 刘红春, 苏利沙, 赵占正, 等. 血清胱抑素C评估慢性肾脏病患者肾小球滤过率的应用研究[J]. 中华检验医学杂志, 2014, 37(3): 184-188. LIU Hongchun, SU Lisha, ZHAO Zhanzheng, et al. The evaluation of glomerular filtration rate in chronic kidney disease patients based on serum CysC[J]. Chin J Lab Med, 2014, 37(3): 184-188. |
[2] | 刘颖, 樊荣, 陈简, 等. 慢性乙型肝炎病毒感染相关肝硬化患者的肾功能及危险因素分析[J]. 南方医科大学学报, 2014, 34(4): 472-476. LIU Ying, FAN Rong, CHEN Jian, et al. Assessment of renal function and risk factors for renal impairment in patients with hepatitis B virus-related liver cirrhosis[J]. J South Med Univ, 2014, 34(4): 472-476. |
[3] | Tanaka M, Suzuki F, Seko Y, et al. Renal dysfunction and hypophosphatemia during long-term lamivudine plus adefovir dipivoxil therapy in patients with chronic hepatitis B[J]. J Gastroenterol, 2014, 49(3): 470-480. |
[4] | Combes B, Shorey J, Barrera A, et al. Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane[J]. Lancet, 1971, 2(7718): 234-237. |
[5] | Ha NB, Ha NB, Garcia RT, et al. Renal dysfunction in chronic hepatitis B patients treated with adefovir dipivoxil[J]. Hepatology, 2009, 50(3): 727-734. |
[6] | Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C[J]. N Engl J Med, 2012, 367(1): 20-29. |
[7] | Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD[J]. Am J Kidney Dis, 2014, 63(5): 713-735. |
[8] | Levey AS, Coresh J, Balk E, et al. National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification[J]. Ann Intern Med, 2003, 139(2): 137-147. |
[9] | 钟爱民, 刘燕鸣, 陈红, 等. 血清胱抑素-C是反映肾小球滤过功能的敏感指标[J]. 临床肾脏病杂志, 2004, 4(4): 166-167. ZHONG Aimin, LIU Yanming, CHEN Hong, et al. Serum cystatin C is a sensitive and accurate marker of glomerular filtration rate[J]. J Clin Nephrol, 2004, 4(4):166-167. |
[10] | Hemmelgarn BR, Manns BJ, Lloyd A, et al. Relation between kidney function, proteinuria, and adverse outcomes[J]. JAMA, 2010, 303(5): 423-429. |
[11] | Amet S, Bronowicki JP, Thabut D, et al. Prevalence of renal abnormalities in chronic HBV infection: The HARPE study[J]. Liver Int, 2015, 35(1): 148-155. |
[12] | Tan LK, Gilleece Y, Mandalia S, et al. Reduced glomerular filtration rate but sustained virologic response in HIV/hepatitis B co-infected individuals on long-term tenofovir[J]. J Viral Hepat, 2009, 16(7): 471-478. |
[13] | Mauss S, Berger F, Filmann N, et al. Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B[J]. Hepatol, 2011, 55: 1235-1240. |
[14] | Kim YJ, Cho HC, Sinn DH, et al. Frequency and risk factors of renal impairment during long-term adefovir dipivoxil treatment in chronic hepatitis B patients[J]. J Gastroenterol Hepatol, 2012, 27(2): 306-312. |
[15] | 张斌, 万谟彬. 肝肾综合征发病机理[J]. 世界感染杂志, 2002, 2(5-6): 385-387. ZHANG Bin, WAN Mobin. The pathogenesis of hepatorenal syndrome[J]. Infection Journal of the World, 2002, 2(5-6): 385-387. |
[16] | Chen N, Wang W, Huang Y, et al. Community-based study on CKD subjects and the associated risk factors[J]. Nephrol Dial Transplant, 2009, 24(7): 2117-2123. |
[17] | Zeng CH, Chen HM, Wang RS, et al. Etiology and clinical characteristics of membranous nephropathy in Chinese patients[J]. Am J Kidney Dis, 2008, 52(4): 691-698. |
[18] | Thyagarajan SP, Thirunalasundari T, Subramanian S, et al. Serum and tissue positivity for hepatitis B virus markers in histopathologically proven glomerulonephropathies[J]. J Med Microbiol, 1989, 29(4): 243-249. |